Literature DB >> 813958

Orgotein efficacy in ameliorating side effects due to radiation therapy. I. Double-blind, placebo-controlled trial in patients with bladder tumors.

F Edsmyr, W Huber, K B Menander.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 813958

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


× No keyword cloud information.
  10 in total

1.  Orgotein (superoxide dismutase): a drug for the amelioration of radiation-induced side effects. A double-blind, placebo-controlled study in patients with bladder tumours.

Authors:  K B Menander-Huber; F Edsmyr; W Huber
Journal:  Urol Res       Date:  1978

Review 2.  On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Dennis P Riley; Jay L Zweier; Christoph Thiemermann; Zhi-Qiang Wang; Daniela Salvemini
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 3.  Superoxide dismutase for therapeutic use: clinical experience, dead ends and hopes.

Authors:  L Flohé
Journal:  Mol Cell Biochem       Date:  1988-12       Impact factor: 3.396

Review 4.  The expanding role of oxygen free radicals in clinical medicine.

Authors:  M A Katz
Journal:  West J Med       Date:  1986-04

Review 5.  Role of superoxide dismutase in modification of radiation injury.

Authors:  A Petkau
Journal:  Br J Cancer Suppl       Date:  1987-06

6.  Double-blind study with Serocytol "Muqueuse urinaire" and "S.R.E." in patients with urological disorders.

Authors:  J Frick; H Joos; G Kunit
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

Review 7.  Biologically active derivatives of fatty acids: prostaglandins, thromboxanes, and endoperoxides.

Authors:  F A Kuehl; J L Humes; G C Beveridge; C G Van Arman; R W Egan
Journal:  Inflammation       Date:  1977-12       Impact factor: 4.092

Review 8.  Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis.

Authors:  Fleur T van de Wetering; Leen Verleye; H Jervoise N Andreyev; Jane Maher; Joan Vlayen; Bradley R Pieters; Geertjan van Tienhoven; Rob J P M Scholten
Journal:  Cochrane Database Syst Rev       Date:  2016-04-25

9.  Superoxidase dismutase (SOD) topical use in oncologic patients: treatment of acute cutaneous toxicity secondary to radiotherapy.

Authors:  Alvaro Manzanas García; María Concepción López Carrizosa; Carmen Vallejo Ocaña; Pilar Samper Ots; José María Delgado Pérez; Emilia Carretero Accame; Pilar Gómez-Serranillos; Luis de la Morena del Valle
Journal:  Clin Transl Oncol       Date:  2008-03       Impact factor: 3.405

Review 10.  Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.

Authors:  Theresa A Lawrie; John T Green; Mark Beresford; Linda Wedlake; Sorrel Burden; Susan E Davidson; Simon Lal; Caroline C Henson; H Jervoise N Andreyev
Journal:  Cochrane Database Syst Rev       Date:  2018-01-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.